Home › Phenylketonuria › Indiana › Indianapolis
Phenylketonuria clinical trials in Indianapolis, IN
6 studies for Phenylketonuria are looking for participants at sites in and around Indianapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Immune Modulation During Palynziq® Treatment in Adults (IMPALA)
RecruitingPhase 4
- Indiana University School of Medicine, Indianapolis
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Subjects With Phenylketonuria
RecruitingPhase 1
- Indiana University, Indianapolis
A Study of Sepiapterin in Participants With Phenylketonuria (PKU)
RecruitingPhase 3
- Indiana University School of Medicine, Indianapolis
A Study of MZE782 in Adults With PKU
RecruitingPhase 2
- Indiana University School of Medicine, Indianapolis
A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)
RecruitingObservational study
- Indiana University School of Medicine, Indianapolis
A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)
RecruitingObservational study
- Riley Children's Hospital/ Indiana University Health, Indianapolis
About Phenylketonuria
In phenylketonuria (PKU), your body can't process phenylalanine, an amino acid in most foods. Read about genetics, screening, and special diets.
More about Phenylketonuria on MedlinePlus
Phenylketonuria trials in other cities
- Dallas, TX7 studies
- Pittsburgh, PA7 studies
- Chicago, IL6 studies
- Portland, OR5 studies
- Salt Lake City, UT4 studies
- Atlanta, GA4 studies
- Tampa, FL3 studies
- Boston, MA3 studies
- Milwaukee, WI3 studies
- Aurora, CO3 studies
- Nashville, TN3 studies
Other studies in Indianapolis
- Non-Small Cell Lung Cancer32 studies
- Cancer (all types)24 studies
- Heart Failure24 studies
- Obesity22 studies
- Breast Cancer19 studies
- Ovarian Cancer18 studies
- Metastatic Cancer17 studies
- Colorectal Cancer17 studies
- Cardiovascular Disease16 studies
- Lung Cancer16 studies
- Type 1 Diabetes14 studies
- Overweight14 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.